MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN)

Clinical trials for MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) explained in plain language.

Never miss a new study

Get alerted when new MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) trials appear

Sign up with your email to follow new studies for MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Breakthrough injection shows promise for devastating kidney conditions

Disease control Completed

This Phase 3 study tested whether pegcetacoplan injections could help people with rare kidney diseases called C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN). The trial involved 124 participants who received either the actual drug or p…

Matched conditions: MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN)

Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN)

Get alerted when new MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) trials appear

Breakthrough injection shows promise for devastating kidney conditions